A turning point for cancer treatment: Monocytes boost T-cells in immunotherapy

In recent decades, immunotherapy has transformed cancer treatment, offering effective options for diseases once considered uncurable, such as melanoma, lung, and bladder cancers. What began as laboratory research has now moved to real-world clinical applications, providing new possibilities for patients facing a range of challenging conditions.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup